Brown-Forman (BFB) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
18 Jun, 2026Executive summary
Annual Meeting scheduled for July 23, 2026, at Churchill Downs, Louisville, KY, with voting on directors, executive compensation, and auditor ratification.
Board emphasizes balancing heritage with innovation, focusing on long-term value and generational success.
Company returned $427 million in dividends and repurchased $400 million in stock during fiscal 2026.
Fiscal 2026 saw a 1% decrease in reported net sales and a 10% decrease in reported operating income, with flat organic sales and a 2% organic operating income decline.
Voting matters and shareholder proposals
Shareholders will vote on: election of eleven directors, advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor for fiscal 2027.
Board recommends voting FOR all proposals.
Shareholders may also vote on any other business properly brought before the meeting.
Board of directors and corporate governance
Board consists of eleven nominees, including six independent directors, four Brown family members, and one management director.
Chairman is a Brown family member; CEO and Chairman roles are separated.
Board committees: Audit, Compensation, Corporate Governance and Nominating, and Executive.
Board voluntarily maintains a majority of independent directors and fully independent Compensation and Audit Committees.
Annual self-assessment and director tenure limits are in place.
Latest events from Brown-Forman
- Director elections, compensation, and auditor ratified; record free cash flow and restructuring announced.BFB
AGM 202624 Jul 2026 - Net sales fell 2% and EPS dropped 8% as emerging markets offset developed market declines.BFB
Q3 20269 Jul 2026 - Bold new strategy and campaign target global growth, innovation, and premiumization.BFB
Investor Day 20259 Jul 2026 - Organic growth continues despite reported declines and market volatility.BFB
Q3 20258 Jul 2026 - Organic growth offset divestitures, but profit and EPS declined; FY26 headwinds expected.BFB
Q4 20258 Jul 2026 - Net sales fell 1%, but gross margin and cash flow improved; 2027 outlook flat with cost headwinds.BFB
Q4 20265 Jun 2026 - Emerging markets and premium brand expansion drive growth amid U.S. demand softness.BFB
UBS Global Consumer and Retail Conference11 Mar 2026 - Operating income rose 25% and gross margin expanded, despite a 1% sales decline.BFB
Q4 20241 Feb 2026 - Sales and profit declined, but organic growth guidance and dividend increases were reaffirmed.BFB
Q1 202522 Jan 2026